91 results
Forrest Classification of Upper GI Bleeding
Acute Hemorrhage
  Ia - Active Spurting, Re-bleeding Risk 60-100%
Spurting, Re-bleeding Risk ... Oozing, Re-bleeding Risk ... Clot, Re-bleeding Risk ... Base, Re-bleeding Risk ... diagnosis #endoscopy #gastroenterology
Central Venous Catheter site selection - Clinical Decision Aid
IJ vs Subclavian vs Supraclavicular vs Femoral by
Femoral by ease and risk ... of infection, DVT ... #Management #CriticalCare ... Locations #Sites #Infections
Tuberculosis Testing

LATENT TB
• LTBI is diagnosed when an asymptomatic patient has a positive TST or IGRA
to decrease the risk ... • The lifetime risk ... infection in patients ... or intermediate risk ... used to exclude pulmonary
Clostridium Dificile Risk by Antibiotic Class

Pooled and study-specific risk estimates of community-associated CDI risk by antibiotic
Clostridium Dificile Risk ... study-specific risk ... #CDifficile #Infection ... #Association #Pharmacology ... #Class #Risk #Clindamycin
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
. tuberculosis infections ... lymph nodes Risk ... • Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... Inhibitor: • Risk
Pulmonary Embolism Treatment
Systemic Thrombolysis
 - Exclude contraindications.
 - Indications:
   - Massive PE (definite indication)
submassive PE (risk ... 50mg IV) - 2% risk ... of ICH and 6% risk ... who are higher risk ... AcutePE #Management #CriticalCare
Pulmonary Embolism - Risk Stratification and Prognostication based on scores and clinical features

 • Bova score
Pulmonary Embolism ... - Risk Stratification ... @nickmmark #Pulmonary ... #Embolism #Risk ... stratification #criticalcare
NSAID Selectivity Spectrum
COX-2 Selective NSAID - Celecoxib
 • Increased risk for CV events
 • Decreased risk
Celecoxib • Increased risk ... events • Decreased risk ... but still retain activity ... at increased CV risk ... selectivity #spectrum #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
. tuberculosis infections ... lymph nodes Risk ... • Pulmonary fibrotic ... • HIV: 2/3 pulmonary ... Inhibitor: • Risk
COVID-19: ICU Guidelines for the Non-Intensivist
Infection Control
Risk Factors for Severe Disease
Initial Laboratory Workup
COVID-19 Specific Medications
Respiratory
Cardiac
Hematologic
Neuro/Sedation

#COVID19 #ICU
Non-Intensivist Infection ... Control Risk Factors ... #COVID19 #ICU #criticalcare